Literature DB >> 29324061

The Prediction of Deterioration of Nutritional Status during Chemoradiation Therapy in Patients with Esophageal Cancer.

Sofia C M Rietveld1, Jill E Witvliet-van Nierop1, Karen Ottens-Oussoren1, Donald L van der Peet2, Marian A E de van der Schueren1.   

Abstract

Patients with esophageal cancer are at high risk of developing malnutrition during neoadjuvant chemoradiation therapy (CRT), which in turn is associated with postoperative morbidity. The aim of the study is to explore whether parameters of a complete pre-treatment nutritional status may predict deterioration of nutritional status during CRT in patients with esophageal cancer. In this prospective cohort study, 101 patients with esophageal cancer treated with CRT were included. Data of patient characteristics, tumor classification, performance score, %weight change, body mass index, fat (free) mass index, phase angle, handgrip strength, energy- and protein intake, and use of (additional) dietary supplements were collected. A prediction model was constructed to identify predictive parameters for deterioration in nutritional status (defined as weight loss of >5% and/or decline in fat free mass of ≥1.4 kg) during CRT. Nutritional status deteriorated in 49 patients (49%) during CRT. The only predictor for deterioration in nutritional status was fat free mass index (OR 1.21 (90% CI: 1.03 - 1.42)). Patients with a higher fat free mass index are at increased risk of deterioration in nutrition status during CRT. Results suggest that all patients should be carefully supervised during CRT, regardless of their nutritional status before start of CRT.

Entities:  

Mesh:

Year:  2018        PMID: 29324061     DOI: 10.1080/01635581.2018.1412481

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  2 in total

1.  Perceptions and experiences of nutritional management needs for patients with esophageal cancer during the peri-radiotherapy period: A qualitative study.

Authors:  Peiru Wang; Xiang Zheng; Zebing Luo; Yiru Wang; Zhijun Guo; Yuhua Zhou
Journal:  Asia Pac J Oncol Nurs       Date:  2022-01-21

2.  A Prospective Phase II Study of Simultaneous Modulated Accelerated Radiotherapy Concurrently With CDDP/S1 for Esophageal Squamous Cell Carcinoma in the Elderly.

Authors:  SuPing Guo; FangJie Liu; Hui Liu; YingJia Wu; XuHui Zhang; WenFeng Ye; GuangYu Luo; QiWen Li; NaiBin Chen; Nan Hu; Bin Wang; Jun Zhang; MaoSheng Lin; HuiXia Feng; Bo Qiu
Journal:  Front Oncol       Date:  2021-11-25       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.